Researchers developed a fast, defined method to generate vascular organoids from human iPSCs by simultaneous transcription factor activation driving endothelial and mural lineage differentiation. The organoids form functional microvascular networks capable of connecting to host vasculature upon implantation. This system provides a scalable platform for vascular biology, tissue engineering, and regenerative medicine.